<DOC>
	<DOCNO>NCT01774604</DOCNO>
	<brief_summary>The purpose study ass whether peri-procedural administration rectal indomethacin , compare placebo , reduce incidence post-ERCP pancreatitis .</brief_summary>
	<brief_title>Rectal Indomethacin Prevent Post-Endoscopic Retrograde Cholangiopancreatography ( ERCP ) Pancreatitis</brief_title>
	<detailed_description />
	<mesh_term>Pancreatitis</mesh_term>
	<mesh_term>Indomethacin</mesh_term>
	<criteria>1 . Scheduled ERCP DartmouthHitchcock 2 . Age great 18 year old 3 . Ability provide write informed consent 1 . Inability provide write informed consent 2 . ERCP perform diagnosis and/or treatment acute pancreatitis 3 . Current ongoing acute pancreatitis 4 . Previously document allergy NonSteroidal AntiInflammatory Drugs ( NSAIDs ) 5 . Contraindication NSAID therapy ( creatinine level &gt; 1.4 active peptic ulcer disease ) , already take NSAIDs ( aspirin therapy cardioprotection ) 6 . Pregnant nursing mother</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Post ERCP acute pancreatitis</keyword>
	<keyword>Post Fine Needle Aspiration ( FNA ) acute pancreatitis</keyword>
	<keyword>Indomethacin</keyword>
	<keyword>Rectal Non Steroidal Anti-Inflammatory Drugs ( NSAIDs )</keyword>
</DOC>